Clinical Trial Update: To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of OTX-DED for short-term treatment of signs and symptoms of dry eye disease has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OTX-DED (dexamethasone)

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2023-02-22